Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer

for
Gynecologycal Cancer
Location: Winston-Salem NC, Charlotte NC
Sponsor: Wake Forest University Health Sciences

Sex: Female

Age: 50+

Code: NCT07046936

Recruiting

A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

for
Locally Advanced or Metastatic Malignant Solid Tumors
Location: New Hyde Park NY, Hackensack NJ, Fairfax VA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07287995

Phase 1, Phase 2, Recruiting

The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.

for
Cancer
Location: College Station TX, Plano TX, Dallas TX, Waxahachie TX,
Sponsor: Baylor Research Institute

Sex: All

Age: 18+

Code: NCT05371756

Recruiting

A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

for
Solid Tumor Malignancies
Location: Fairfax VA, Miami FL, Cincinnati OH, Grand Rapids MI,
Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT07207707

Phase 1, Recruiting

Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies

for
Breast Cancer, Gynecologic Cancer
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 18+

Code: NCT07166042

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

for
Advanced/Metastatic Solid Tumors, Bladder Cancer,
Location: Boston MA, Newton MA, New Haven CT, Trumbull CT,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07090499

Phase 1, Recruiting

A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation

for
Advanced Solid Tumors
Location: Fort Myers FL, Houston TX
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT07172919

Phase 2, Recruiting

A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)

for
Hematopoietic and Lymphoid System Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06192875

Recruiting

TLN-372 in Advanced KRAS Mutant Solid Tumors

for
KRAS Mutant Solid Tumors
Location: Boston MA, New York NY, Toronto, Grand Rapids MI,
Sponsor: Treeline Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07204340

Phase 1, Recruiting

Voices: Messages of Wisdom and Hope in the Face of Illness

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07381179

Recruiting

Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06304168

Recruiting

Olutasidenib Combined With Co-targeted Therapy in Relapsed or Refractory IDH1-mutated Myeloid Malignancies Harboring Activated Signaling Pathway Mutations

for
Targeted Therapy, IDH1-Mutated Malignancies, Mutations
Location: Miami FL, Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07032727

Phase 2, Recruiting

Testing a Brief Motivational Intervention to Increase Physical Activity for Cancer Survivors

for
Cancer
Location: Stony Brook NY
Sponsor: Stony Brook University

Sex: All

Age: 0+

Code: NCT07215091

Recruiting

Multi-Cancer Detection Observational Cohort Study

for
Cancer
Location: Jacksonville FL, Rochester MN, Scottsdale AZ
Sponsor: Mayo Clinic

Sex: All

Age: 21+

Code: NCT06962995

Recruiting

A Study of Questionnaires in Adolescents and Young Adults With Cancer

for
Adolescents and Young Adults With Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 15 - 39

Code: NCT07212166

Recruiting

A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE)

for
Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07298096

Recruiting

A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, New Haven CT, Grand Rapids MI,
Sponsor: Ottimo Pharma Limited

Sex: All

Age: 18+

Code: NCT07266428

Phase 1, Phase 2, Recruiting

A Chaplain-clinician Led Spiritual Care (PEACE) Intervention on Spiritual/Religious Beliefs Related to Medical Care in Patients With Advanced Cancer: a Pilot Clinical Trial

for
Spiritual Care, Advanced Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07246954

Recruiting

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumors,
Location: Houston TX, San Antonio TX, Scottsdale AZ
Sponsor: SHY Therapeutics

Sex: All

Age: 18+

Code: NCT07705334

Phase 1, Recruiting

Vaginal Dilator Therapy After Pelvic Radiation

for
Pelvic Radiotherapy, Vaginal Stenosis, Pelvic Cancer,
Location: Durham NC
Sponsor: Duke University

Sex: Female

Age: 18+

Code: NCT07216456

Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial